Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast Cancer
Clinical trial NCT03153163 · COMPLETED
Trial details
- NCT number
- NCT03153163
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2018-09-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.